ARDS News and Press, Aridis Pharmaceuticals Inc. From 06/15/20

SAN JOSE, Calif. , June 15, 2020 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today that it has appointed D...

Gainers:  Sorrento Therapeutics (NASDAQ: SRNE ) +195% . More news on: Sorrento Therapeutics, Inc., Aurora Cannabis Inc., Bridgeline Digital, Inc., Stocks on the move, , Read more ...

Aridis Pharmaceuticals (NASDAQ: ARDS ): Q1 GAAP EPS of -$0.73 misses by $0.19 . More news on: Aridis Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

SAN JOSE, Calif. , May 12, 2020 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, today reported financial and corporate result...

Gainers: Portola Pharmaceuticals (NASDAQ: PTLA ) +130% . More news on: Portola Pharmaceuticals, Inc., CleanSpark, Inc., Genprex, Inc., Stocks on the move, , Read more ...

Aridis Pharmaceuticals (NASDAQ: ARDS ) enrolls first COVID-19 patient in its ongoing Phase 3 clinical trial of AR-301 , a monoclonal antibody against S. aureus induced pneumonia in patients who were already on mechanical ventilators. More news on: Aridis Pharmaceuticals, Inc., Healthcare ...

SAN JOSE, Calif. , May 4, 2020 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today the enrollment of its fir...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

SAN JOSE, Calif. , April 29, 2020 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today its participation in M...

Aridis Pharmaceuticals (NASDAQ: ARDS ): Q4 GAAP EPS of -$0.63 beats by $0.17 . More news on: Aridis Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...